Replimune Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Woburn MA United States (2015)

Organization Overview

First Clinical Trial
2017
NCT03767348
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Replimune Inc.